在患有卵巢癌的患者中,肠道微生物组与PARP抑制剂疗效相关
Mika Okazawa-Sakai1,2, Shunsuke A Sakai3,4, Ichinosuke Hyodo5
1Department of Gynecologic Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan.
Journal of gynecologic oncology
|October 25, 2024
概括
肠道细菌Phascolarctobacterium的高水平与BRCA1/2-突变卵巢癌患者治疗PARPi治疗的更长的无进展生存时间相关.
科学领域:
- 在瘤学瘤学.
- 微生物组研究 微生物组研究
- 遗传学 遗传学是一种遗传学.
背景情况:
- 卵巢癌的治疗往往涉及到多种ADP-ribose聚合酶抑制剂 (PARPi).
- 肠道微生物组在癌症治疗疗效中的作用是一个新兴的研究领域.
- 在卵巢癌中,BRCA1/2突变会影响PARPi反应.
研究的目的:
- 调查肠道微生物组组成和PARPi在卵巢癌患者的疗效之间的关联.
- 为了确定特定的肠道微生物是否可以预测治疗反应.
- 基于BRCA1/2突变状态来探索微生物组合的差异.
主要方法:
- 使用16S rRNA基因测序进行便微生物组分析.
- 循环瘤DNA (ctDNA) 分析,以确定BRCA1/2突变状态.
- 使用考克斯比例危险模型,对微生物丰富度和无进展生存率 (PFS) 之间的相关性分析.
主要成果:
- 在BRCA1/2-突变患者中,没有特定的肠道微生物与PFS显著相关.
- 在BRCA1/2-突变阴性患者中,在基线时高丰度的Phascolarctobacterium与显著更长的PFS (14.0与5.9个月) 有关.
- 在最后一次随访时,在没有疾病进展的患者中,Phascolarctobacterium的丰度显著更高.
结论:
- 在接受PARPi治疗的BRCA1/2-突变阴性卵巢癌患者中,Phascolarctobacterium的便丰度高与延长的PFS有关.
- 这些发现表明Phascolarctobacterium是PARPi疗效的潜在预测生物标志物.
- 需要进一步的研究来阐明这种关联背后的机制.
更多相关视频
相关概念视频
01:27Microbiota of the Stomach and Small Intestine
The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
01:27Microbiota of the Large Intestine
The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
01:18Functions of the Gut Microbiota
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
01:18Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
01:28Microbiota of the Urogenital Tract
The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...